
Mr Michael Whitlow is an entrepreneur and investor with over 20 years’ experience across small-cap and early-stage companies in multiple sectors and jurisdictions.

Mr Nicholas Tulloch has advised companies on the UK capital markets for over 20 years, working for several well-known investment banks and stockbrokers, including Cazenove, Arbuthnot and Cenkos.

Dr Peter Sargent brings over 18 years of experience working within the life sciences sector, with extensive commercial, scientific and operational expertise across drug and diagnostic development.

Mr Ian Bagnall is a Chartered Accountant with over three decades of experience across corporate finance, operational leadership and investment management. He also holds a BSc in Biochemistry and Physiology.

Hayley Close joins Physiomics with 5 years of business development experience.

Jesse Thissen is an experienced statistician with a background in large pharma (AstraZeneca) as well as Biotech, FMCG and CRO companies.

Frances Brightman is a model-informed drug-development specialist, with 25 years of experience.

Léa Sta is an applied mathematician with experience in cell signalling and receptor-ligand models.

Ghaith is a pharmacokinetics and pharmacodynamics (PK/PD) modelling specialist with experience in both industry and academic environments.

Malek Hajjawi brings expertise in pharmacometrics, population pharmacokinetic/pharmacodynamic (PK/PD) modelling, physiologically based pharmacokinetic (PBPK) modelling, and model-informed drug development.

Charmaine Fraser brings with her a wealth of Administrative and Managerial experience.

Dr Hitesh Mistry, is a modelling and simulation specialist within the pharmaceutical industry.

Dr Claire Villette is a biomedical computational scientist with 9 years of experience.

Dr Christophe Chassagnole has led systems biology and bio-computing projects for over 20 years.